Архивы Eurasian Pharma Awards - Page 2 of 2 - Publications

Olainfarm presented the best socially responsible project of the…

The award in the nomination “Socially Responsible Project of the Year” of the competition Eurasian Pharma Awards 2022 was received by Olainfarm for the Zdorovie.ru Doc project.

The Zdorovie.ru Doc project is aimed at supporting the doctors’ mental health. This is the first project in the Eurasian region that has combined new technologies and services for daily work, evidence-based medicine and psychological support needed in doctors’ professional activities. The idea of the application appeared with the emergence of COVID-19 pandemic, when doctors faced an increased workload, and then was successfully implemented.

Executive Director of Olainfarm Elena Bushberg receiving an award highlighted, “Our project is social because it takes care of doctors. Its idea appeared during the pandemic, when we realized that doctors very often were burnt out and were becoming emotionally powerless. The program helps the doctor to work with patients in a digital format and make decisions much better based on these records. We receive thanks from doctors every day”.

Eurasian Pharma Awards

Rano Shakhavdinova is the “Marketing Director of the Year”…

Marketing Director of NIKA PHARM Rano Shakhavdinova won the main prize in the nomination “Marketing Director of the Year” of the competition Eurasian Pharma Awards 2022.

While managing the marketing department, Rano optimized the company’s product portfolio, built the division structure and business processes, and determined the strategy for the development of the product portfolio. In 2021 successful marketing strategy allowed NIKA PHARM to climb to the 6th place among all pharmaceutical producers represented in the Uzbek market.

Eurasian Pharma Awards

Hayyom Sharapov, CEO of the company MEROS PHARM is…

The CEO of MEROS PHARM, Hayyom Sharapov received an award in the nomination “Leader of the Year” in the contest for the Eurasian Pharma Awards 2022.

As the top manager of the leading pharmaceutical distribution company in Uzbekistan, Hayyom Sharapov, amidst a changing market and uncertainty, finds the right solutions and, together with his team, achieves the desired targets.

“I would like to thank our team for their support, without them, I couldn’t have achieved the results that make our company the market leader”, highlighted Hayyom.

Eurasian Pharma Awards

Arminas Macevicius is the winner of the Eurasian Pharma…

Arminas Macevicius, the Vice President for the Eurasia region at STADA, is the winner of the Eurasian Pharma Awards 2022 in the nomination “Leader of the Year”.

In 2021, under Arminas’s leadership, the integration of the TAKEDA portfolio into STADA’s product mix that required radical transformation of the business in Uzbekistan, Belarus, and Kazakhstan was carried out successfully. The achievements of the CIS cluster under Arminas’s guidance and the actual doubling of the business in the region became the main reasons for transferring the cluster to direct subordination to the head office in Germany, with a renaming to the Eurasia region in August 2022. Today, STADA is the number one company in the Consumer Health segment in Kazakhstan, Uzbekistan, Armenia, and Azerbaijan.

Mr. Macevicius expressed gratitude for the award, saying, “I want to wish everyone good health because it is our main goal and mission! Let this evening be dedicated to health, not only ours but also that of our patients.”

Eurasian Pharma Awards

MEROS PHARM from Uzbekistan is the winner in the…

Uzbek company MEROS PHARM is the winner in the nomination “Distributor of the Year” of the contest Eurasian Pharma Awards 2022.

MEROS PHARM is the leader in the pharmaceutical market of Uzbekistan with a market share of over 20%. The company collaborates with suppliers from 50 countries worldwide and offers more than 7000 product items in the market. With a team of over 1000 employees, MEROS PHARM has gained the trust of over 3500 loyal customers.

The CEO of MEROS PHARM Khayyom Sharapov receiving the award emphasized: “Thank you to our partners, it’s great to have you! This victory is not only ours but also, of course, your choice!!”.

Eurasian Pharma Awards

VIVA PHARM from Kazakhstan is the winner in the…

One of the winners in the nomination “Local Company of the Year” of the contest for the Eurasian Pharma Awards 2022 was the Kazakh company VIVA PHARM.

VIVA PHARM has been successfully operating in the pharmaceutical market of Kazakhstan for 23 years. Over the past 3 years, the company’s production volume has increased by 2.5 times. The company is actively developing exports to the countries of Central Asia.

The company’s owner Baturbek Mashkeev was invited to receive the award.

Eurasian Pharma Awards

NIKA PHARM is the winner of the Eurasian Pharma…

One of the winners of the competition for the Eurasian Pharma Awards 2022 in the nomination “Company of the Year (Local)” was the Uzbek company “NIKA PHARM”.

In 2021, the company remained a prominent player in the local pharmaceutical industry in Uzbekistan, achieving high sales and establishing itself as one of the largest exporters in the country.

CEO of ASKLEPIY Group Said Talibov expressed gratitude to the NIKA PHARM team for exceptional work and highlighted that the award serves as a driving force for the company’s continuous growth.

Eurasian Pharma Awards

Bayer is a winner of the Eurasian Pharma Awards…

The Global Pharmaceutical Leaders’ Club has started accepting applications for the 4th competition for the Eurasian Pharma Awards. Many leading companies have already become winners of this prestigious competition several times. Remember who won awards last year and share positive emotions with the best companies!

Bayer is the only company that has won the “Company of the Year (International)” award for three years in a row. As a leader in the global OTC market, Bayer remains committed to developing its presence in the CIS region. The company is represented in 8 countries in the region and has been one of the fastest-growing companies in the Consumer Health segment for the past 3 years. Bayer has made remarkable progress in the two largest markets in the region: sales in Uzbekistan have tripled over the past three years, and the company remains a leader in the Kazakhstan market.

Taigun Gunay, Cluster Head for Russia and the CIS, emphasized: “This award demonstrates recognition of our attention to developing our presence in the markets of the CIS countries as a whole and Uzbekistan in particular. We will continue to invest and develop this region together to take care of the patients’ health today and continue to implement the advanced experience of European companies in the countries where we operate”.